SRPT
SRPT
US8036071004
Sarepta Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.89B EUR
1.9B EUR
2.3B EUR
2.26B EUR
Enterprise Value
2.2B EUR
2.37B EUR
2.87B EUR
2.5B EUR
Valuation Multiples
Trailing P/E
--
--
35.31x
--
Forward P/E
7.4x
--
--
--
Price to Sales
0.95x
0.96x
1.05x
1.55x
Price to Book
1.23x
1.24x
1.53x
1.98x
EV/Revenue
1.11x
1.2x
1.31x
1.72x
EV/EBITDA
-125.33x
174.08x
37.27x
--
Price to FCF (P/FCF)
85.16x
25.32x
21.22x
7.19x
EV/FCF
99.25x
31.65x
26.51x
7.95x
FCF Yield
1.17%
3.95%
4.71%
13.9%
ende